封面
市场调查报告书
商品编码
1673021

生命科学 BPO 市场:按服务类型、最终用户和地区划分

Life Sciences BPO Market, By Service Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球生命科学 BPO 市场规模预估为 4,628.3 亿美元,预计到 2032 年将达到 1,1168.1 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 13.4%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 4628.3亿美元
效能资料 2020-2024 预测期 2025-2032
预测期:2025 年至 2032 年复合年增长率 13.40% 2032 年金额预测 11,168.10亿美元
数字。生命科学 BPO 市场区域份额(%)(2025 年)
生命科学 BPO 市场-IMG1

生命科学 BPO 市场是向医疗保健产业提供的外包服务,包括製药、生技和医疗设备公司。我们帮助生命科学公司专注于其核心业务:药物发现、产品开发和商业化。监管事务管理、临床资料管理、医学写作、出版、药物安全检测、医疗监测和其他临床测试相关服务外包给专业的 BPO 提供者。成本优化、获得先进基础设施和专业知识、复杂的法律规范以及简化业务的需求等因素正在推动生命科学领域外包的增加。

市场动态

全球生命科学 BPO 市场的成长是由生命科学公司对成本优化的不断增长的需求,以及获得 BPO服务供应商提供的先进基础设施和专业知识的好处所驱动。此外,药物开发和核准的法律规范每年都变得越来越复杂,因此有必要将非核心功能外包。此外,医疗保健产业的变化动态,例如向价值驱动型医疗保健的转变,也正在推动生命科学公司透过策略性外包来简化业务。然而,资料安全问题、对关键功能的控制丧失以及与供应商管理相关的营运挑战等因素可能会阻碍市场成长。新兴市场的医疗保健支出、生物相似药和基因组药物的开发以及人工智慧/区块链的整合以增强 BPO 服务可能为市场成长提供机会。

研究的主要特点

本报告对全球生命科学 BPO 市场进行了详细分析,并以 2024 年为基准年,展示了预测期(2025-2032 年)的市场规模(以十亿美元计)和年复合成长率(CAGR%)。

它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球生命科学 BPO 市场的主要企业根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行分析。

研究涉及的主要企业包括 Cognizant、埃森哲、Genpact、EXL services、Catalent 等。

本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球生命科学 BPO 市场报告迎合了该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员可以透过全球生命科学 BPO 市场分析中使用的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 监管情景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章 全球生命科学 BPO 市场-COVID-19 疫情的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020 年至 2032 年按服务类型分類的全球生命科学 BPO 市场(十亿美元)

  • 介绍
  • 医药外包
  • 翻译
  • 成品剂型
  • 包装
  • 药物研发
  • 临床前研究
  • 临床实验室研究
  • 监管服务
  • 药品安全监控
  • 医疗设备外包
  • 电子製造服务
  • 成品
  • 原料及零件
  • 监理咨询服务
  • 产品设计与开发服务
  • 产品测试服务
  • 产品实施服务
  • 产品升级服务
  • 产品维护服务
  • 合约销售和市场外包
  • 其他的

6. 2020 年至 2032 年全球生命科学 BPO 市场(以最终用户划分)(十亿美元)

  • 介绍
  • 製药公司
  • 生技公司
  • 合约研究组织
  • 医疗设备公司
  • 学术和政府机构

7. 2020 年至 2032 年全球生命科学 BPO 市场(按地区划分)(单位:十亿美元)

  • 介绍
  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第八章 竞争格局

  • 公司简介
    • Accenture, Plc
    • Boehringer Ingelheim GmbH
    • Cognizant Technology Solutions
    • Infosys
    • Genpact Limited
    • ProMab BIoTechnologies, Inc
    • Charles River Laboratories International, Inc
    • Catalent, Inc.
    • Covance, Inc.
    • Fareva
    • ICON, Plc
    • DSM
    • Health Decisions, Inc.
    • IQVIA
    • Laboratory Corporation of America Holdings
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences

第 9 章分析师建议

  • 兴衰
  • 一致的机会地图

第十章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI24

Global Life Sciences Bpo Market is estimated to be valued at USD 462.83 Bn in 2025 and is expected to reach USD 1,116.81 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 462.83 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.40% 2032 Value Projection: USD 1,116.81 Bn
Figure. Life Sciences Bpo Market Share (%), By Region 2025
Life Sciences BPO Market - IMG1

The life sciences BPO market comprises outsourcing services provided to pharmaceutical, biotechnology, medical device companies and others in the healthcare industry. It helps life sciences companies to focus on core activities of drug discovery, product development and commercialization. Services like regulatory affairs management, clinical data management, medical writing and publishing, pharmacovigilance, medical monitoring and other clinical trial related services are outsourced to specialized BPO players. Factors such as cost optimization, access to advanced infrastructure and expertise, complex regulatory frameworks and need to streamline operations has increased outsourcing in the life sciences sector.

Market Dynamics:

Global life sciences BPO market growth is driven by rising need for cost-optimization among life sciences companies coupled with benefits of access to advanced infrastructure and expertise delivered by BPO service providers. Moreover, regulatory frameworks for drug development and approval have become highly complex over the years, thus, necessitating outsourcing of non-core functionalities. Changing dynamics of the healthcare industry including shift towards value-based care has also prompted life sciences players to streamline their operations through strategic outsourcing. However, factors such as data security concerns, loss of control over critical functions and operational challenges associated with vendor management can hamper the market growth. Growing healthcare expenditure in developing regions, development of biosimilars & genomic drugs and integration of AI/blockchain to enhance BPO services can offer market growth opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global life sciences BPO market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global life sciences BPO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Cognizant, Accenture, Genpact, EXL services, and Catalent

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global life sciences BPO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life sciences BPO market

Detailed Segmentation-

  • By Service Type
    • Pharmaceutical outsourcing
    • Contract manufacturing market
    • API
    • Finished dose form
    • Packaging
    • Contract research organizations
    • Drug discovery
    • Preclinical studies
    • Clinical trial studies
    • Regulatory services
    • Pharmacovigilance
    • Medical devices outsourcing
    • Contract manufacturing market
    • Electronic manufacturing services
    • Finished goods
    • Raw materials/components
    • Contract research organizations
    • Regulatory consulting services
    • Product design and development services
    • Product testing services
    • Product implementation services
    • Product upgrade services
    • Product maintenance services
    • Contract sales & market outsourcing
    • Others
  • By End User
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Contract Research Organizations Medical Device Companies
    • Academic Institutes & Government Organizations
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Accenture, Plc
    • Boehringer Ingelheim GmbH
    • Cognizant Technology Solutions
    • Infosys
    • Genpact Limited
    • ProMab Biotechnologies, Inc
    • Charles River Laboratories International, Inc
    • Catalent, Inc.
    • Covance, Inc.
    • Fareva
    • ICON, Plc
    • DSM
    • Health Decisions, Inc.
    • IQVIA
    • Laboratory Corporation of America Holdings
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Service Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Life Sciences BPO Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Life Sciences BPO Market, By Service Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Pharmaceutical outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Contract manufacturing market
  • API
  • Finished dose form
  • Packaging
    • Contract research organizations
  • Drug discovery
  • Preclinical studies
  • Clinical trial studies
  • Regulatory services
  • Pharmacovigilance
  • Medical devices outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Contract manufacturing market
  • Electronic manufacturing services
  • Finished goods
  • Raw materials/components
    • Contract research organizations
  • Regulatory consulting services
  • Product design and development services
  • Product testing services
  • Product implementation services
  • Product upgrade services
  • Product maintenance services
  • Contract sales & market outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Life Sciences BPO Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Pharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biotechnology Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Medical Device Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic Institutes & Government Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Life Sciences BPO Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Accenture, Plc
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boehringer Ingelheim GmbH
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cognizant Technology Solutions
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Infosys
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Genpact Limited
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ProMab Biotechnologies, Inc
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Charles River Laboratories International, Inc
    • Catalent, Inc.
    • Covance, Inc.
    • Fareva
    • ICON, Plc
    • DSM
    • Health Decisions, Inc.
    • IQVIA
    • Laboratory Corporation of America Holdings
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact